Commercial Supply Alogliptin Benzoate (CAS: 850649-62-6) Related Intermediates:
6-Chloro-3-methyluracil CAS: 4318-56-3
2-Cyanobenzyl Bromide CAS: 22115-41-9
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS: 334618-23-4
2-[(6-Chloro-3,4-dihydro-3-Methyl-2,4-dioxo-1(2h)-pyriMidinyl)Methyl]benzonitrile CAS: 865758-96-9
Commercial Supply Trelagliptin Succinate (CAS: 1029877-94-8) Related Intermediates:
6-Chloro-3-Methyluracil CAS: 4318-56-3
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS: 334618-23-4
2-Cyano-5-Flurobenzyl Bromide CAS: 421552-12-7
| Chemical Name | 6-Chloro-3-Methyluracil |
| CAS Number | 4318-56-3 |
| CAT Number | RF-PI141 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C5H5ClN2O2 |
| Molecular Weight | 160.56 |
| Melting Point | 278.0~280.0℃ |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Appearance | White to Light Yellow Powder |
| Identification | HPLC: The retention time of the major peak in chromatograms corresponds to that in the reference standard |
| Purity / Analysis Method | ≥99.0% (HPLC) |
| Max Single Impurity | ≤0.50% (HPLC) |
| Total Impurities | ≤0.50% (HPLC) |
| Moisture (K.F) | ≤0.50% |
| Loss on Drying | ≤1.0% |
| Residue on Ignition | ≤0.10% |
| Test Standard | Enterprise Standard |
| Usage | Alogliptin Benzoate, Trelagliptin Succinate Intermediate |
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 6-Chloro-3-methyluracil (CAS: 4318-56-3) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and active pharmaceutical ingredient (API) synthesis.
6-Chloro-3-methyluracil (CAS: 4318-56-3) is used in the synthesis of Alogliptin Benzoate (CAS: 850649-62-6) and Trelagliptin Succinate (CAS: 1029877-94-8).
Alogliptin Benzoate (CAS: 850649-62-6) is a type-2 diabetes medication, and it is a type of serine protease dipeptidyl peptidase IV (DPP-4) inhibitor developed by the Japanese company Takeda. Alogliptin, used alone or in combination with other blood sugar-lowering medication, is usually well-tolerated in type-2 diabetes patients.
Trelagliptin Succinate (CAS: 1029877-94-8) (SYR-472) is a selective, long acting dipeptidyl peptidase-4 (DPP-4) inhibitor. An antidiabetic agent. Orally active DPP-4 inhibitor that produces clinically and statistically significant improvements in glycaemic control in patients with type 2 diabetes.